Alexza resubmits ADASUVE NDA to U.

announced today that it has resubmitted its ADASUVE New Drug Software to the U.S. Food and Medication Administration in response to a Total Response Letter received in-may 2012. ADASUVE NDA Regulatory Update In May 2012, Alexza received a CRL from the FDA. The May 2012 CRL also included feedback on Alexza’s draft item labeling. Related StoriesNew analysis finds illogical thoughts as most predictive of schizophrenia riskNovel analysis tool identifies link between unfavorable symptoms of schizophrenia and adverse medical outcomesVraylar capsules now approved by FDA to take care of schizophrenia, bipolar disorder in adultsThere were no fresh clinical or safety issues identified and there were no various other deficiencies outlined in the CRL.Today, Gardner spearheads humanitarian attempts worldwide and has supplied desperately needed medical care to more than 10,000 people in Central America, SOUTH USA, Africa, Europe and Asia. To honor his accomplishments, the American Academy of Doctor Assistants will identify Gardner with the Humanitarian PA of the entire year Award for his excellent commitment to human privileges at AAPA’s Annual PA Conference in Toronto, Ontario on May 28. Related StoriesGenetic carrier screening: an interview with Don Hardison, CEO of Good Start GeneticsCancer analysis improvements in England: an interview with Lucy Elliss-BrookesHealthcare technology interpersonal event of the year opens entries’Jack is an inspired PA and a powerful humanitarian who is in a position to make complex circumstances understandable,’ stated Nicaraguan Pastor Julio Cortez, of Centers of Hope Mission International.